Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/9/24 16:30 | 8/7/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | S.m | -61 | 0.1899 | 0 | -322 | -5 | 6,318 | D | |||||||||||||||
8/7/24 16:30 | 8/5/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | S.m | -41 | 0.1870 | 0 | -220 | -3 | 6,640 | D | |||||||||||||||
8/5/24 16:53 | 8/1/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | S.m | -71 | 0.2033 | 0 | -350 | -5 | 6,860 | D | |||||||||||||||
7/30/24 17:16 | 7/26/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | S.m | -315 | 0.2286 | 0 | -1,379 | -16 | 7,210 | D | |||||||||||||||
5/18/23 16:27 | 5/17/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Hahn Brian M. | MD | O | SVP Fina | S | -7 | 1.95 | 0 | -4 | -7 | 53 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |